MAPT and Alzheimer disease: To uncover the mystery of how these devastating proteins work in a living AD patient’s brain, positron emission tomography (PET) combing specific radiotracers to target beta-amyloid plaques or aberrant tau proteins provides a chance to study the pathogenesis mechanism of AD [4].